- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Company XYZ reported strong Q2FY24 performance. Revenue from operations grew 11% year-on-year (YoY) to ₹ 721 Cr, with half-year revenue up 10% to ₹ 1,402 Cr. EBITDA surged 22% YoY to ₹ 224 Cr, achieving a healthy 31.1% margin. Profit after tax (PAT) also saw a significant 24% YoY jump to ₹ 185 Cr, boosting EPS by 24% to ₹ 11.02. The company is net cash positive, reporting ₹ (310) Cr net debt.
Growth was broad-based, with Formulations revenue up 11% and APIs up 10%. India Formulations led geographical expansion with 13% YoY growth, alongside strong showings in Emerging Markets (+8%) and Developed Markets (+12%).
Strategic focus includes aggressive new product launches, with 8 introduced in India in Q2FY24 and 15-20 more planned for H2FY24, backed by an R&D spend of 4.6% of revenue. The company also declared a second interim dividend of ₹ 6 per equity share for FY24. Management's outlook emphasizes expanding the India branded business, strengthening the US pipeline, growing in Emerging Markets, and boosting API competitiveness.